{"denoms":[{"counts":[{"groupId":"BG000","value":"165"},{"groupId":"BG001","value":"164"},{"groupId":"BG002","value":"329"}],"units":"Participants"}],"groups":[{"description":"brentuximab vedotin 1.8 mg/kg every 3 weeks by IV infusion","id":"BG000","title":"Brentuximab Vedotin"},{"description":"placebo every 3 weeks by IV infusion","id":"BG001","title":"Placebo"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"18","upperLimit":"71","value":"33"},{"groupId":"BG001","lowerLimit":"18","upperLimit":"76","value":"32"},{"groupId":"BG002","lowerLimit":"18","upperLimit":"76","value":"32"}]}]}],"dispersionType":"FULL_RANGE","paramType":"MEDIAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"89"},{"groupId":"BG001","value":"67"},{"groupId":"BG002","value":"156"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"76"},{"groupId":"BG001","value":"97"},{"groupId":"BG002","value":"173"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"American Indian or Alaska Native"},{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"5"}],"title":"Asian"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"Native Hawaiian or Other Pacific Islander"},{"measurements":[{"groupId":"BG000","value":"10"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"12"}],"title":"Black or African American"},{"measurements":[{"groupId":"BG000","value":"153"},{"groupId":"BG001","value":"156"},{"groupId":"BG002","value":"309"}],"title":"White"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"More than one race"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"3"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"20"},{"groupId":"BG001","value":"19"},{"groupId":"BG002","value":"39"}]}],"title":"Russian Federation"},{"categories":[{"measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"6"},{"groupId":"BG002","value":"10"}]}],"title":"Romania"},{"categories":[{"measurements":[{"groupId":"BG000","value":"9"},{"groupId":"BG001","value":"11"},{"groupId":"BG002","value":"20"}]}],"title":"Hungary"},{"categories":[{"measurements":[{"groupId":"BG000","value":"67"},{"groupId":"BG001","value":"68"},{"groupId":"BG002","value":"135"}]}],"title":"United States"},{"categories":[{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"6"}]}],"title":"United Kingdom"},{"categories":[{"measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"6"},{"groupId":"BG002","value":"10"}]}],"title":"Spain"},{"categories":[{"measurements":[{"groupId":"BG000","value":"5"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"5"}]}],"title":"Czech Republic"},{"categories":[{"measurements":[{"groupId":"BG000","value":"26"},{"groupId":"BG001","value":"28"},{"groupId":"BG002","value":"54"}]}],"title":"Poland"},{"categories":[{"measurements":[{"groupId":"BG000","value":"9"},{"groupId":"BG001","value":"7"},{"groupId":"BG002","value":"16"}]}],"title":"Italy"},{"categories":[{"measurements":[{"groupId":"BG000","value":"8"},{"groupId":"BG001","value":"5"},{"groupId":"BG002","value":"13"}]}],"title":"France"},{"categories":[{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"6"},{"groupId":"BG002","value":"9"}]}],"title":"Serbia"},{"categories":[{"measurements":[{"groupId":"BG000","value":"7"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"9"}]}],"title":"Bulgaria"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"3"}]}],"title":"Germany"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Region of Enrollment","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"87"},{"groupId":"BG001","value":"97"},{"groupId":"BG002","value":"184"}]}],"title":"0"},{"categories":[{"measurements":[{"groupId":"BG000","value":"77"},{"groupId":"BG001","value":"67"},{"groupId":"BG002","value":"144"}]}],"title":"1"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"}]}],"title":"2"}],"description":"0=Normal activity; 1=Symptoms but ambulatory; 2=In bed \\<50% of the time; 3= In bed \\>50% of the time; 4=100% bedridden; 5=Dead","paramType":"COUNT_OF_PARTICIPANTS","title":"Eastern Cooperative Oncology Group Performance Status","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"99"},{"groupId":"BG001","value":"97"},{"groupId":"BG002","value":"196"}]}],"title":"Refractory"},{"categories":[{"measurements":[{"groupId":"BG000","value":"53"},{"groupId":"BG001","value":"54"},{"groupId":"BG002","value":"107"}]}],"title":"Relapse in less than 12 months"},{"categories":[{"measurements":[{"groupId":"BG000","value":"13"},{"groupId":"BG001","value":"13"},{"groupId":"BG002","value":"26"}]}],"title":"Relapse 12 months or later with extranodal disease"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Hodgkin Lymphoma Status after end of Frontline Therapy","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"61"},{"groupId":"BG001","value":"62"},{"groupId":"BG002","value":"123"}]}],"title":"Complete remission"},{"categories":[{"measurements":[{"groupId":"BG000","value":"57"},{"groupId":"BG001","value":"56"},{"groupId":"BG002","value":"113"}]}],"title":"Partial remission"},{"categories":[{"measurements":[{"groupId":"BG000","value":"47"},{"groupId":"BG001","value":"46"},{"groupId":"BG002","value":"93"}]}],"title":"Stable disease"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Best Response to Salvage Therapy pre-ASCT","unitOfMeasure":"Participants"}],"populationDescription":"Intention-to-Treat analysis set"}